Christine POITOU
Christine POITOU
Professeur de Nutrition
Verified email at
Cited by
Cited by
Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss
R Cancello, C Henegar, N Viguerie, S Taleb, C Poitou, C Rouault, ...
Diabetes 54 (8), 2277-2286, 2005
Differential adaptation of human gut microbiota to bariatric surgery–induced weight loss: links with metabolic and low-grade inflammation markers
JP Furet, LC Kong, J Tap, C Poitou, A Basdevant, JL Bouillot, D Mariat, ...
Diabetes 59 (12), 3049-3057, 2010
Links With Metabolic and Low-Grade Inflammation Markers
JP Furet, LC Kong, J Tap, C Poitou, A Basdevant, JL Bouillot, D Mariat, ...
Weight loss regulates inflammation‐related genes in white adipose tissue of obese subjects
K Clément, N Viguerie, C Poitou, C Carette, V Pelloux, CA Curat, A Sicard, ...
The FASEB Journal 18 (14), 1657-1669, 2004
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
P Bedossa, C Poitou, N Veyrie, JL Bouillot, A Basdevant, V Paradis, ...
Hepatology 56 (5), 1751-1759, 2012
Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity
R Cancello, J Tordjman, C Poitou, G Guilhem, JL Bouillot, D Hugol, ...
Diabetes 55 (6), 1554-1561, 2006
Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss
A Divoux, J Tordjman, D Lacasa, N Veyrie, D Hugol, A Aissat, ...
Diabetes 59 (11), 2817-2825, 2010
Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity
C Henegar, J Tordjman, V Achard, D Lacasa, I Cremer, M Guerre-Millo, ...
Genome biology 9 (1), R14, 2008
Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss
J Aron-Wisnewsky, J Tordjman, C Poitou, F Darakhshan, D Hugol, ...
The Journal of Clinical Endocrinology & Metabolism 94 (11), 4619-4623, 2009
Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery
H Sell, A Divoux, C Poitou, A Basdevant, JL Bouillot, P Bedossa, ...
The Journal of Clinical Endocrinology & Metabolism 95 (6), 2892-2896, 2010
Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis
P Richette, C Poitou, P Garnero, E Vicaut, JL Bouillot, JM Lacorte, ...
Annals of the rheumatic diseases 70 (1), 139-144, 2011
Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients
I Magalhaes, K Pingris, C Poitou, S Bessoles, N Venteclef, B Kiaf, ...
The Journal of clinical investigation 125 (4), 1752-1762, 2015
CD14dimCD16+ and CD14+CD16+ Monocytes in Obesity and During Weight Loss: Relationships With Fat Mass and Subclinical Atherosclerosis
C Poitou, E Dalmas, M Renovato, V Benhamo, F Hajduch, M Abdennour, ...
Arteriosclerosis, thrombosis, and vascular biology 31 (10), 2322-2330, 2011
AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial
S Allas, A Caixàs, C Poitou, M Coupaye, D Thuilleaux, F Lorenzini, ...
PloS one 13 (1), e0190849, 2018
Rare genetic forms of obesity: clinical approach and current treatments in 2016
H Huvenne, B Dubern, K Clément, C Poitou
Obesity facts 9 (3), 158-173, 2016
MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
K Clément, H Biebermann, IS Farooqi, L Van der Ploeg, B Wolters, ...
Nature medicine 24 (5), 551-555, 2018
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
TH Collet, B Dubern, J Mokrosinski, H Connors, JM Keogh, ...
Molecular metabolism 6 (10), 1321-1329, 2017
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
K Clément, E van den Akker, J Argente, A Bahm, WK Chung, H Connors, ...
The Lancet Diabetes & Endocrinology 8 (12), 960-970, 2020
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition
C Poitou, N Viguerie, R Cancello, R De Matteis, S Cinti, V Stich, ...
Diabetologia 48 (3), 519-528, 2005
T cell–derived IL-22 amplifies IL-1β–driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes
E Dalmas, N Venteclef, C Caer, C Poitou, I Cremer, J Aron-Wisnewsky, ...
Diabetes 63 (6), 1966-1977, 2014
The system can't perform the operation now. Try again later.
Articles 1–20